Shire PLC | Key People and Executives
Thomas J. W. Dittrich
Chief Financial Officer & Director
Olivier Jean Bohuon
Non-Executive Director
Susan Saltzbart Kilsby
Non-Executive Chairman
Ian T. Clark
Independent Non-Executive Director
Gail D. Fosler
Independent Non-Executive Director
Albert P. L. Stroucken
Independent Non-Executive Director
S. Sara Mathew
Independent Non-Executive Director
Steven H. Gillis
Independent Non-Executive Director
Thomas J. W. Dittrich
Chief Financial Officer & Director
Andreas Eugen Busch
Chief Scientific Officer
Matthew Walker
Head-Technical Operations
Howard Mayer
Chief Medical Officer
David Altarac
SVP & Head-Global Regulatory Affairs
Sheila E. Stranks
Vice President & Deputy Compliance Officer
Robert Dempsey
Head-Ophthalmics Business
Reza Haque
Head-Therapeutics Area
Olivier Jean Bohuon
Non-Executive Director
Scott Hunter
Director-Ophthalmics Business Marketing
Gisele Dion
Chief Accounting Officer
Lisa Adler
Head-Communications & Public Affairs
Gwen Fisher
Head-Communications & Public Affairs
Souheil Salah
Investor Relations Contact
Joanne Cordeiro
Chief Human Resources Officer
Leslie Waltke
Vice President-Human Resources
William R. Mordan
Secretary & General Counsel
Susan Saltzbart Kilsby
Non-Executive Chairman
Ian T. Clark
Independent Non-Executive Director
Gail D. Fosler
Independent Non-Executive Director
Albert P. L. Stroucken
Independent Non-Executive Director
Sara Mathew
Independent Non-Executive Director
Steven H. Gillis
Independent Non-Executive Director
| Address |
4-1-1 Dosho-machi
Osaka Osaka 540
Japan
|
|
Employees
|
- |
| Website |
http://www.takeda.co.jp |
| Updated |
07/08/2019 |
| Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol. |
